| Date Filed | Type | Description |
| 04/03/2023 |
4
| Fishman Corey N. (CEO) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted 275,000 options to buy
@ $1, valued at
$275k
|
|
| 03/14/2023 |
4
| Fishman Corey N. (CEO) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted 14,333 shares
@ $0
Paid exercise price by delivering 5,683 shares
@ $0.96, valued at
$5.5k
Exercised 14,333 options to buy
@ $0 |
|
| 03/15/2022 |
4
| Fishman Corey N. (CEO) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Exercised 215,000 options to buy
@ $0 |
|
| 06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2021 |
4
| Fishman Corey N. (President & CEO) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted 167,500 shares
@ $0
Sold 85,445 shares
@ $1.73, valued at
$147.8k
|
|
| 12/02/2020 |
4
| Fishman Corey N. (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Disposed/sold 2,018 shares
@ $0
Disposed/sold 6,000 options to buy
@ $55.63, valued at
$333.8k
|
|
| 05/04/2020 |
4
| Fishman Corey N. (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Granted 6,000 options to buy
@ $55.63, valued at
$333.8k
|
|
| 04/15/2020 |
4
| Fishman Corey N. (Director) has filed a Form 4 on BIOSPECIFICS TECHNOLOGIES CORP|
Txns:
| Granted 2,018 shares
@ $0 |
|
| 04/15/2020 |
3
| Fishman Corey N. (Director) has filed a Form 3 on BIOSPECIFICS TECHNOLOGIES CORP |
| 06/21/2019 |
4
| Fishman Corey N. (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC|
Txns:
| Granted 25,000 options to buy
@ $12.64, valued at
$316k
Exercised 4,356 restricted stock units
@ $0 |
|
| 02/19/2019 |
4
| Fishman Corey N. (President & CEO) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted 150,000 options to buy
@ $5.8, valued at
$870k
|
|
| 08/21/2018 |
4
| Fishman Corey N. (President & CEO) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Bought 2,000 shares
@ $8.7328, valued at
$17.5k
|
|
| 06/25/2018 |
4
| Fishman Corey N. (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC|
Txns:
| Granted 8,855 options to buy
@ $22.3, valued at
$197.5k
Granted 4,356 restricted stock units
@ $0
Exercised 5,734 restricted stock units
@ $0 |
|
| 05/30/2018 |
4
| Fishman Corey N. (President & CEO) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Converted 33,259 shares
@ $0
Converted 4,050 shares
@ $0
Converted 1,591 shares
@ $0
Bought 3,000 shares
@ $13, valued at
$39k
Converted 33,259 options to buy
@ $0
Converted 4,050 options to buy
@ $0
Converted 1,591 options to buy
@ $0 |
|
| 05/29/2018 |
4
| Fishman Corey N. (President & CEO) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted 127,307 options to buy
@ $13, valued at
$1.7M
|
|
| 05/24/2018 |
3
| Fishman Corey N. (President & CEO) has filed a Form 3 on Iterum Therapeutics plc |
| 06/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/26/2016 |
4
| Fishman Corey N. (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC|
Txns:
| Granted 33,000 options to buy
@ $12.09, valued at
$399k
|
|
| 09/26/2016 |
3/A
| Fishman Corey N. (Director) has filed a Form 3/A on MOMENTA PHARMACEUTICALS INC |
| 09/23/2016 |
3
| Fishman Corey N. (Director) has filed a Form 3 on MOMENTA PHARMACEUTICALS INC |
| 11/18/2014 |
4
| Fishman Corey N. (CFO&COO) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Disposed/sold 24,941 shares
@ $0
Disposed/sold 218,750 options to buy
@ $0.96, valued at
$210k
Disposed/sold 21,574 options to buy
@ $10, valued at
$215.7k
Disposed/sold 12,500 options to buy
@ $10, valued at
$125k
Disposed/sold 50,000 options to buy
@ $7.49, valued at
$374.5k
Disposed/sold 110,000 options to buy
@ $16.15, valued at
$1.8M
|
|
| 05/22/2014 |
4
| Fishman Corey N. (CFO & COO) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Granted 110,000 options to buy
@ $16.15, valued at
$1.8M
|
|
| 02/14/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/26/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |